BUSINESS REPORT: Texas – Innovation Moves Front And Center In Austin
Buisness Facilities Contributed Content
MAY 15, 2013
The device is based on dried blood spot (DBS) technology, which is best known for newborn screening and has many additional commercial uses for clinical trials, bio-banking, population studies and a wide range of medical research. Execution of the state’s agreement is contingent upon finalization of a local incentive package.
73 
Let's personalize your content